Completed PHASE1 INTERVENTIONAL 6-arm NCT05737927

Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

Pharmacodynamics and Pharmacokinetics of Different Coated and Uncoated Formulations of Glucose Beads After Single and Multiple Dose Administration Under Fasting Conditions in Obese Healthy Subjects

Sponsor: ACC GmbH Analytical Clinical Concepts

Conditions Obese

Interventions Glucose 12 g coated beads (47% w/w) Glucose 12 g coated beads (60% w/w) Glucose 12 g uncoated beads Glucose 16 g coated beads (47% w/w) Glucose 8 g coated beads (47% w/w)

Updated 5 times since 2023 Last updated: Sep 15, 2025 Started: Sep 16, 2020 Primary completion: Nov 9, 2020 Completion: Nov 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Obese, this trial is completed. The trial is conducted by ACC GmbH Analytical Clinical Concepts and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE1
Sep 2025 — Oct 2025 [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ACC GmbH Analytical Clinical Concepts
Aphaia Pharma US LLC
Galephar Pharmaceutical Research (PR), Inc.
NovaClin Medical Research Center S.R.L
SC Bioclinica SA

Data source: Aphaia Pharma US LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Timișoara, Romania